Healio Pulmonology has compiled the top news on COPD posted in 2025.Readers were most interested in how pulmonary ...
After smoking for nearly five decades, this 70-year-old parted ways with cigarettes for good after his diagnosis.
The National Lung Health Initiative aims to put these two breathing organs front and centre in health policy and awareness.
Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...
IEAT Partners with AstraZeneca, DLPW, and SSO to Launch a Social Initiative To Improve Quality of Life and Build a Sustainable Health Model for Thai Workers, featuring the “Lung Screening with AI ...
This simple diagram shows a healthy lung (left) and one with chronic obstructive pulmonary disease, or COPD. (AdobeStock) Buy Photo The Gazette offers audio versions of articles using Instaread. Some ...
Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death from disease — on track to be the third by 2035 if nothing changes. Gaps in ...
Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...
Abstract: Chronic Obstructive Pulmonary Disease (COPD) represents a major global health challenge, with early and accurate diagnosis being essential for improving patient outcomes. Traditional ...
Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the Regeneron-partnered drug failed one of a pair of phase 3 chronic obstructive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results